drugset / Trial / NCT01106131
Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to prove effect of glucose reduction that CKD-501 and metformin combination treatment group is non inferiority compare to pioglitazone and metformin combination.
Timeline
- Start
- 2010-05
- Primary completion
- 2012-04
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeglitazone | Small molecule | 0.5 mg | Oral |
| Comparator | Pioglitazone | Small molecule | 15 mg | Oral |